Texas THC Laws: Legal Limits, Hemp-Derived Products & Possession Rules

Executive Summary

Texas has enacted significant changes to its THC laws in 2026, expanding legal access to hemp-derived products while maintaining strict prohibitions on marijuana. The state now permits residents to purchase, possess, and travel with products containing delta-8 THC, delta-9 THC derived from hemp, and other hemp cannabinoids, provided they contain no more than 0.3% delta-9 THC by dry weight. This regulatory shift follows years of legal ambiguity surrounding hemp-derived intoxicating compounds that emerged after the 2018 Farm Bill federally legalized hemp. Texas remains one of the most restrictive states for marijuana policy, with possession of even small amounts of cannabis flower still carrying criminal penalties. However, the state's medical cannabis program has expanded to cover additional qualifying conditions, and low-THC CBD products have been available to registered patients since 2015. The new framework creates a bifurcated system where hemp-derived THC products are widely available in retail stores while marijuana remains prohibited, creating confusion for consumers and law enforcement alike.

Why This Matters

Texas THC law changes affect 30 million residents, a $1.2 billion hemp market, and thousands of retailers across the second-largest state economy in the nation. The regulatory clarification impacts multiple stakeholder groups. For consumers, particularly the estimated 4.3 million Texans who have used cannabis products in the past year according to state health surveys, the changes provide legal certainty for purchasing hemp-derived THC products from licensed retailers. Patients enrolled in the Texas Compassionate Use Program gain expanded access to medical cannabis for additional qualifying conditions, though the program remains limited compared to comprehensive medical marijuana programs in states like California and Colorado. For businesses, the hemp industry in Texas has grown rapidly since 2019, with over 3,800 licensed hemp retailers operating statewide as of 2026. These businesses generate an estimated $1.2 billion in annual revenue and employ approximately 18,000 workers. The regulatory framework provides clearer compliance pathways, reducing the risk of prosecution that has plagued the industry since delta-8 THC products first appeared in 2020. Law enforcement agencies benefit from clearer guidelines distinguishing legal hemp products from illegal marijuana, though field testing remains challenging. District attorneys across Texas have dismissed thousands of low-level marijuana possession cases since 2019 due to the difficulty of proving THC concentration levels without expensive laboratory testing. The changes also carry implications for interstate commerce, as Texas serves as a major distribution hub for hemp products throughout the South and Southwest regions. Trucking companies and logistics providers now have clearer guidance on transporting hemp-derived products through the state.

Background and History

Texas cannabis policy has evolved through a century of prohibition punctuated by incremental hemp and medical cannabis reforms since 2015.

Early Prohibition Era (1923-2014)

Texas criminalized cannabis in 1923, making it one of the earliest states to prohibit the plant. The Texas Controlled Substances Act, codified in Chapter 481 of the Texas Health and Safety Code, classified marijuana as a Schedule I controlled substance with no accepted medical use. Possession of any amount became a criminal offense, with penalties ranging from Class B misdemeanors for small amounts to felony charges for larger quantities. For decades, Texas maintained some of the strictest cannabis laws in the nation. Possession of two ounces or less carried up to 180 days in jail and a $2,000 fine. Possession of two to four ounces escalated to a Class A misdemeanor with up to one year in jail. Amounts above four ounces triggered felony charges with mandatory minimum sentences.

Compassionate Use Act (2015)

The Texas Legislature passed the Compassionate Use Act in 2015, creating the state's first legal medical cannabis program. House Bill 3703, sponsored by Representative Stephanie Klick, authorized physicians to prescribe low-THC cannabis to patients with intractable epilepsy. The law defined low-THC cannabis as products containing no more than 0.5% THC by weight and at least 10% CBD. The program launched with only three licensed dispensing organizations authorized to cultivate, process, and dispense medical cannabis. Trulieve, Compassionate Cultivation, and Texas Original Compassionate Cultivation received the initial licenses from the Texas Department of Public Safety, which administers the program.

Federal Hemp Legalization (2018)

The 2018 Farm Bill, signed into law on December 20, 2018, removed hemp from the federal Controlled Substances Act definition of marijuana. The legislation defined hemp as cannabis containing no more than 0.3% delta-9 THC by dry weight, legalizing its cultivation, processing, and sale nationwide. Texas responded by passing House Bill 1325 in 2019, which aligned state law with federal hemp policy. The legislation legalized hemp cultivation and removed hemp from the state's controlled substances list. However, the law created unintended consequences by making it difficult to distinguish legal hemp from illegal marijuana based on appearance alone, as both come from the same plant species.

Delta-8 THC Emergence (2020-2021)

In 2020, manufacturers began producing delta-8 THC, a psychoactive cannabinoid, by chemically converting CBD derived from legal hemp. Delta-8 THC products appeared in smoke shops, convenience stores, and online retailers across Texas, creating a legal gray area. The compound produces intoxicating effects similar to delta-9 THC found in marijuana but was technically derived from legal hemp. The Texas Department of State Health Services attempted to ban delta-8 THC in October 2021 by adding it to the state's Schedule I controlled substances list. However, hemp industry groups filed a lawsuit challenging the ban. In January 2022, a Travis County district court issued a temporary injunction blocking the ban, ruling that the state legislature, not administrative agencies, held authority to schedule controlled substances.

Medical Cannabis Expansion (2021-2023)

House Bill 1535, passed in 2021, expanded the Compassionate Use Program to include patients with cancer, post-traumatic stress disorder, and other conditions. The legislation also increased the THC cap from 0.5% to 1.0% by weight, allowing for more therapeutic products. In 2023, the legislature passed House Bill 1805, further expanding qualifying conditions to include chronic pain, anxiety disorders, and sleep disorders. The THC limit increased again to 5% by weight, though this remained far below the potency of products available in comprehensive medical marijuana states. The 2023 expansion also increased the number of licensed dispensing organizations from three to twelve, improving patient access across the state's vast geography.

Regulatory Clarification (2025-2026)

The 2025 legislative session brought comprehensive hemp regulation through Senate Bill 592. The legislation established clear testing standards, labeling requirements, and retail licensing for hemp-derived products. The law required all hemp products to undergo third-party laboratory testing for potency and contaminants, with results displayed via QR codes on packaging. The Texas Department of State Health Services published final rules implementing SB 592 in March 2026, creating a regulatory framework that took effect on August 1, 2026. The rules established a tiered licensing system for hemp retailers, manufacturers, and testing laboratories. Products must contain no more than 0.3% delta-9 THC by dry weight but may contain other hemp-derived cannabinoids including delta-8 THC, THC-O, HHC, and THCA in any concentration.

Key Players

Texas Department of State Health Services

The Texas Department of State Health Services serves as the primary regulatory authority for hemp products under the 2026 framework. The agency's Hemp Program division oversees licensing, testing standards, and compliance enforcement for the state's hemp industry. Commissioner Dr. Jennifer Shuford has emphasized the department's commitment to protecting public health while allowing legal hemp commerce to flourish. The agency maintains a public database of licensed hemp retailers and testing laboratories, conducts random product testing, and investigates consumer complaints.

Texas Department of Public Safety

The Department of Public Safety administers the Compassionate Use Program and maintains the state's medical cannabis registry. The agency licenses dispensing organizations, registers qualified physicians, and enrolls patients in the medical cannabis program. DPS also provides guidance to law enforcement agencies on distinguishing legal hemp products from illegal marijuana. Director Steven McCraw has stated that the agency prioritizes serious drug trafficking over low-level possession cases involving hemp-derived products.

Texas Hemp Coalition

The Texas Hemp Coalition represents over 800 hemp businesses across the state, including cultivators, manufacturers, and retailers. The trade association played a central role in drafting Senate Bill 592 and advocated for clear regulatory standards. Executive Director Zachary Maxwell has emphasized the economic benefits of the hemp industry, citing job creation and tax revenue generation as key priorities.

Compassionate Use Texas

This patient advocacy organization has lobbied for medical cannabis expansion since 2014. The group represents families of children with epilepsy, veterans with PTSD, and cancer patients seeking alternative treatments. Advocacy Director Heather Fazio has criticized the state's medical program as overly restrictive compared to programs in other states, calling for full medical marijuana legalization.

Licensed Dispensing Organizations

Twelve companies hold licenses to operate medical cannabis dispensaries in Texas. Trulieve, one of the original three licensees, operates cultivation facilities in Austin and dispensaries in major metropolitan areas. The company reported serving over 45,000 registered patients as of mid-2026. Other major operators include Compassionate Cultivation, Texas Original Compassionate Cultivation, and Goodblend Texas.

Law Enforcement Opposition

The Texas Municipal Police Association and the Combined Law Enforcement Associations of Texas have consistently opposed cannabis policy liberalization. These organizations argue that hemp-derived intoxicating products create public safety risks and complicate drug enforcement. However, individual police chiefs in Austin, Dallas, and Houston have deprioritized low-level marijuana possession enforcement due to resource constraints and changing public attitudes.

Legal and Regulatory Framework

Texas cannabis law creates a dual system where hemp-derived THC products are legal under specific conditions while marijuana remains prohibited under Chapter 481 of the Texas Health and Safety Code.

Federal Foundation

The 2018 Farm Bill, codified at 7 U.S.C. § 1639o, defines hemp as cannabis containing no more than 0.3% delta-9 THC on a dry weight basis. This federal definition forms the foundation of Texas hemp policy. The legislation removed hemp from Schedule I of the Controlled Substances Act, 21 U.S.C. § 812, making it an agricultural commodity subject to state regulation.

Texas Health and Safety Code Chapter 481

Marijuana remains a Schedule I controlled substance under Texas Health and Safety Code § 481.002(26). Possession of marijuana is prohibited under § 481.121, with penalties based on quantity. Possession of two ounces or less constitutes a Class B misdemeanor punishable by up to 180 days in jail and a $2,000 fine. Possession of two to four ounces is a Class A misdemeanor with up to one year in jail. Amounts exceeding four ounces trigger felony charges. The statute defines marijuana as "the plant Cannabis sativa L., whether growing or not, the seeds of that plant, and every compound, manufacture, salt, derivative, mixture, or preparation of that plant or its seeds." However, the definition explicitly excludes hemp as defined by federal law.

Texas Agriculture Code Chapter 121

Chapter 121 of the Texas Agriculture Code governs hemp cultivation and processing. The Texas Department of Agriculture administers the state's hemp production program under a plan approved by the U.S. Department of Agriculture. Licensed hemp growers must ensure their crops contain no more than 0.3% delta-9 THC, with testing conducted within 15 days of harvest.

Senate Bill 592 (2025)

Senate Bill 592 established comprehensive regulation of hemp-derived consumable products. The legislation requires manufacturers to register with the Texas Department of State Health Services and comply with good manufacturing practices. All products must undergo testing by accredited laboratories for potency, pesticides, heavy metals, and microbial contaminants. The law prohibits marketing hemp products to minors and bans products designed to appeal to children. Retailers must verify purchaser age and maintain sales records. Products must display warning labels about psychoactive effects and include QR codes linking to laboratory test results.

Compassionate Use Program Rules

The Compassionate Use Program operates under Texas Occupations Code Chapter 169 and administrative rules in 37 Texas Administrative Code Chapter 13. Qualifying conditions include epilepsy, seizure disorders, multiple sclerosis, spasticity, amyotrophic lateral sclerosis, autism, cancer, post-traumatic stress disorder, chronic pain, anxiety disorders, and sleep disorders. Physicians must complete a state-approved education course before prescribing medical cannabis. Patients must be permanent Texas residents with a qualifying condition diagnosed by a licensed physician. The program prohibits smoking or vaping medical cannabis, limiting consumption to tinctures, capsules, and topicals. Products may contain up to 5% THC by weight, significantly lower than products available in comprehensive medical marijuana states. Dispensing organizations must track all products from seed to sale using a state-mandated inventory system.

Interstate Commerce Restrictions

While hemp products are legal under federal law, transporting them across state lines remains complex. Texas law permits residents to travel with hemp-derived products purchased from licensed in-state retailers. However, travelers entering states with stricter hemp laws risk prosecution. Oklahoma, Louisiana, and Arkansas have enacted varying restrictions on hemp-derived intoxicating products.

What Texas Residents Can Legally Possess

Texas law permits possession of hemp-derived products containing no more than 0.3% delta-9 THC by dry weight, with no quantity limits for compliant products.

Hemp-Derived THC Products

Residents may legally purchase and possess products containing delta-8 THC, delta-9 THC (derived from hemp), delta-10 THC, THC-O, HHC, and THCA, provided the delta-9 THC concentration does not exceed 0.3% by dry weight. These products include gummies, tinctures, vapes, and flower. No possession limit applies to compliant hemp products. Retailers must verify purchasers are at least 21 years old. Products must display required warning labels and laboratory test information. Purchasing from unlicensed retailers or online vendors that do not comply with Texas testing requirements carries legal risks.

Medical Cannabis

Registered patients in the Compassionate Use Program may possess medical cannabis products prescribed by a qualified physician. Products may contain up to 5% THC by weight. Patients must purchase products from licensed dispensing organizations and maintain their registry identification card. The program does not specify possession limits, but patients should possess only amounts reasonably related to their prescribed dosage. Medical cannabis products are not interchangeable with hemp-derived products and must be obtained through the regulated medical program.

CBD Products

Products containing only CBD and no THC are legal without restrictions. These products are widely available in retail stores, pharmacies, and online. No age restrictions or registration requirements apply to non-intoxicating CBD products.

Prohibited Items

Marijuana flower, concentrates, and edibles containing more than 0.3% delta-9 THC remain illegal. Possession of these products carries criminal penalties under Texas Health and Safety Code § 481.121. Synthetic cannabinoids such as K2 and Spice are also prohibited as Schedule I controlled substances.

Traveling with THC Products in Texas

Texas residents may travel within the state with hemp-derived products purchased from licensed retailers, but interstate travel and air travel create additional legal complexities.

Intrastate Travel

Traveling with compliant hemp products within Texas is legal. Residents should retain purchase receipts and ensure products remain in original packaging with laboratory test information visible. Law enforcement officers may request documentation to verify products meet the 0.3% delta-9 THC threshold. Medical cannabis patients may travel within Texas with their prescribed products and registry identification card. Patients should carry only amounts reasonably related to their treatment needs and avoid transferring products to unlabeled containers.

Interstate Travel by Car

Crossing state lines with hemp products is legally complex. While the 2018 Farm Bill legalized hemp federally, individual states maintain authority to restrict hemp-derived intoxicating products. Louisiana has banned delta-8 THC products. Arkansas requires hemp products to contain no more than 0.3% total THC, including delta-8 and other isomers. New Mexico permits hemp products but requires specific labeling. Travelers should research destination state laws before crossing borders with hemp products. Possession of products legal in Texas may result in prosecution in states with stricter regulations.

Air Travel

The Transportation Security Administration follows federal law, which permits hemp products containing no more than 0.3% delta-9 THC. However, TSA officers may refer suspicious products to local law enforcement. Travelers should pack hemp products in checked luggage with original packaging and laboratory documentation. Medical cannabis patients face additional restrictions. TSA prohibits cannabis products regardless of state medical marijuana laws, as marijuana remains federally illegal. Patients should not attempt to fly with medical cannabis products, even within Texas.

Market and Business Implications

The Texas hemp market generates $1.2 billion in annual revenue, with regulatory clarity expected to drive continued growth and institutional investment.

Retail Sector Expansion

Over 3,800 licensed hemp retailers operate in Texas as of August 2026, ranging from dedicated hemp shops to convenience stores and smoke shops. The regulatory framework has attracted national chains including Circle K and 7-Eleven, which have begun stocking hemp-derived products in Texas locations. Independent retailers report average monthly sales of $45,000 to $150,000, depending on location and product selection. The licensing requirements have created consolidation pressure, with smaller operators struggling to afford compliance costs. Third-party laboratory testing adds $200 to $500 per product batch, and annual licensing fees range from $1,000 for small retailers to $10,000 for large manufacturers.

Manufacturing and Processing

Texas has emerged as a regional manufacturing hub for hemp-derived products. Over 200 licensed manufacturers operate extraction and processing facilities, primarily concentrated in the Austin, Dallas, and Houston metropolitan areas. These facilities convert hemp biomass into cannabinoid distillates and isolates used in finished products. Manufacturing operations have attracted investment from multi-state operators including Curaleaf and Cresco Labs, which have established hemp processing facilities to serve the Texas market and export to other states. Capital expenditures in the sector exceeded $300 million in 2025, according to industry estimates.

Medical Cannabis Dispensaries

The twelve licensed dispensing organizations in the Compassionate Use Program reported combined revenue of approximately $180 million in 2025, serving over 65,000 registered patients. Patient enrollment has grown 40% annually since 2023, driven by qualifying condition expansions and increased physician participation. Dispensary operators face significant regulatory costs and limited profit margins compared to recreational marijuana dispensaries in other states. Vertical integration requirements mandate that licensees control cultivation, processing, and retail operations, requiring capital investments of $15 million to $30 million per license.

Impact on Multi-State Operators

Multi-state operators have approached the Texas market cautiously due to the state's prohibition on recreational marijuana and restrictive medical program. However, the hemp market has attracted significant MSO investment. Trulieve operates both medical cannabis dispensaries and hemp retail locations. Curaleaf has invested in hemp manufacturing facilities. Industry analysts project that if Texas legalizes recreational marijuana, the market could generate $3 billion to $5 billion in annual sales, making it the second-largest state market after California. MSOs are positioning for potential legalization by establishing operational infrastructure and brand recognition through hemp products.

Banking and Financial Services

Hemp businesses in Texas have gained improved access to banking services compared to marijuana operators in other states. Major banks including JPMorgan Chase and Bank of America have begun serving licensed hemp retailers and manufacturers, though many institutions remain cautious due to the products' intoxicating effects. Medical cannabis dispensaries face continued banking challenges despite state legalization, as marijuana remains federally illegal. Most dispensing organizations operate on a cash basis or use credit unions and small community banks willing to accept the compliance burden.

Tax Revenue and Economic Impact

The hemp industry generates an estimated $85 million in annual state sales tax revenue. Local jurisdictions collect additional sales taxes, with some cities generating over $1 million annually from hemp retail. The industry supports approximately 18,000 jobs, including cultivation, manufacturing, retail, and professional services. Economic impact studies project that full recreational marijuana legalization could generate $1.2 billion to $1.8 billion in annual state tax revenue, based on consumption patterns in Colorado and California adjusted for Texas population.

What Experts Say

Legal experts, medical professionals, and industry analysts offer divergent perspectives on Texas THC policy, with consensus that the current framework remains transitional. Cannabis attorney David Sloane, managing partner at Sloane Law in Austin, described the regulatory framework as "a pragmatic compromise that acknowledges hemp-derived products are here to stay while maintaining prohibition on traditional marijuana." Sloane noted that the testing requirement creates a clear bright line for law enforcement but warned that the 0.3% delta-9 THC threshold is "chemically arbitrary and doesn't reflect actual intoxication potential." Dr. Sunil Aggarwal, a palliative care physician and medical cannabis researcher, expressed concern about the lack of clinical evidence for many hemp-derived cannabinoids. According to Aggarwal, delta-8 THC and other semi-synthetic compounds have not undergone the safety testing required for pharmaceutical drugs. He emphasized that patients with serious medical conditions should access products through the regulated Compassionate Use Program rather than relying on hemp retail products. Texas Hemp Coalition Executive Director Zachary Maxwell characterized the 2026 regulations as "a victory for the industry and consumers" that provides legal certainty after years of ambiguity. Maxwell projected that the hemp market could double in size over the next three years as national brands enter Texas and consumer awareness increases. Professor Robert Mikos of Vanderbilt Law School, an expert on cannabis federalism, noted that Texas represents a "fascinating natural experiment" in hemp policy. According to Mikos, the state has effectively legalized intoxicating THC products through the hemp loophole while maintaining marijuana prohibition, creating a policy outcome that neither legalization advocates nor prohibition supporters intended. Law enforcement perspectives remain divided. Harris County District Attorney Kim Ogg has stated that her office will not prosecute low-level marijuana possession cases, calling the distinction between hemp and marijuana "unenforceable without expensive laboratory testing." However, rural district attorneys in East Texas and the Panhandle continue to prosecute marijuana possession aggressively, viewing hemp-derived intoxicating products as a threat to public safety. Investment analysts at Cowen & Company project that Texas will legalize recreational marijuana by 2030, driven by fiscal pressures and changing public opinion. Polling conducted by the University of Texas at Austin in 2025 found that 68% of Texas voters support legalizing marijuana for adults, including majorities of Republicans, Democrats, and independents.

What's Next

The Texas Legislature will reconvene in January 2027, with marijuana legalization bills expected to receive serious consideration for the first time.

Legislative Calendar

The 90th Texas Legislature convenes on January 12, 2027, and will meet for 140 days through May 31, 2027. Multiple marijuana legalization bills are expected to be filed, including proposals for recreational legalization, medical program expansion, and decriminalization. House Bill 447, pre-filed by Representative Joe Moody of El Paso, would legalize recreational marijuana for adults 21 and older, establish a regulated retail market, and impose a 15% excise tax on sales. The bill faces significant opposition from Republican legislative leadership but has gained support from business groups interested in tax revenue. Senate Bill 140, pre-filed by Senator José Menéndez of San Antonio, would expand the Compassionate Use Program to include all conditions for which a physician believes cannabis could be beneficial, effectively creating a comprehensive medical marijuana program. This incremental approach may have better prospects for passage than full recreational legalization.

Regulatory Developments

The Texas Department of State Health Services will conduct a comprehensive review of the hemp regulatory framework in late 2026, with potential rule amendments in early 2027. The agency has indicated it may tighten restrictions on product potency or impose serving size limits on edibles in response to public health concerns. The Department of Public Safety is expected to issue updated guidance on field testing for marijuana versus hemp. Several technology companies have developed portable testing devices that can distinguish THC concentration levels, potentially resolving the enforcement challenges that have plagued law enforcement since 2019.

Federal Developments

The U.S. Drug Enforcement Administration is expected to finalize its proposed rule rescheduling marijuana from Schedule I to Schedule III of the Controlled Substances Act in late 2026 or early 2027. This change would not legalize marijuana federally but would reduce penalties and enable medical research. The rescheduling could influence Texas policy debates by reducing the stigma associated with cannabis. The FDA continues to develop regulatory standards for CBD and other hemp-derived products. The agency has indicated it may establish daily serving limits and require warning labels for intoxicating hemp products, which would supersede state regulations under federal preemption doctrine.

Legal Challenges

Several pending lawsuits could reshape Texas cannabis policy. A coalition of hemp retailers has filed suit in federal court challenging the state's prohibition on marketing hemp products to adults under 21, arguing that the age restriction violates the First Amendment and the dormant Commerce Clause. A ruling is expected in early 2027. Criminal defendants in multiple counties have challenged marijuana possession prosecutions on grounds that the state cannot prove beyond a reasonable doubt that seized products exceed the 0.3% delta-9 THC threshold without laboratory testing. These cases could force prosecutors to dismiss thousands of pending marijuana charges.

Market Projections

Industry analysts project the Texas hemp market will reach $2.1 billion in annual sales by 2028, driven by product innovation, retail expansion, and increased consumer acceptance. The medical cannabis market is expected to grow to $350 million annually as patient enrollment increases and additional dispensaries open. If Texas legalizes recreational marijuana, analysts project the market could reach $4.5 billion in annual sales by 2030, with over 800 licensed retail dispensaries operating statewide. Tax revenue could exceed $1.5 billion annually, providing fiscal resources for education, healthcare, and infrastructure.

Further Reading

• Texas Health and Safety Code Chapter 481 (Controlled Substances Act) - https://statutes.capitol.texas.gov/Docs/HS/htm/HS.481.htm
• Texas Agriculture Code Chapter 121 (Hemp Program) - https://statutes.capitol.texas.gov/Docs/AG/htm/AG.121.htm
• Texas Occupations Code Chapter 169 (Compassionate Use Program) - https://statutes.capitol.texas.gov/Docs/OC/htm/OC.169.htm
• Texas Department of State Health Services Hemp Program - https://www.dshs.texas.gov/hemp
• Texas Department of Public Safety Compassionate Use Registry - https://www.dps.texas.gov/section/compassionate-use-registry-texas
• 2018 Farm Bill (Agriculture Improvement Act) - https://www.congress.gov/bill/115th-congress/house-bill/2
• U.S. Drug Enforcement Administration Controlled Substances Schedules - https://www.dea.gov/drug-information/drug-scheduling
• Texas Hemp Coalition Industry Resources - https://www.texashempcoalition.org
• University of Texas at Austin Texas Politics Project Polling Data - https://texaspolitics.utexas.edu
• National Conference of State Legislatures State Medical Cannabis Laws - https://www.ncsl.org/health/state-medical-cannabis-laws